Why Celestica Stock Is Plummeting Today

Celestica reported Q1 adjusted EPS of $2.16 on revenue of $4.05 billion, beating earnings estimates by $0.08 per share while sales were roughly in line with expectations. The company also raised full-year guidance to $19 billion in revenue and $10.15 in adjusted EPS, up from prior targets of $17 billion and $8.75. Despite the strong beat and higher outlook, the stock fell 15.7% intraday, suggesting a valuation-driven selloff.

Analysis

The market is treating a strong print as a de-rating event, which usually happens when the forward revision is not just good but forces investors to re-anchor the entire earnings power curve. That matters here because the company’s step-up in guidance likely compresses the implied growth runway: when estimates move this fast, the stock often trades on “prove it” execution risk for the next 1-2 quarters rather than the headline beat. In other words, the near-term pain is less about fundamentals and more about the market pulling forward multiple expansion that had already priced in a clean AI/supply-chain narrative.

The second-order implication is that suppliers and adjacent hardware names exposed to the same customer end-markets may face a sympathy read-through if investors start distinguishing between cyclical acceleration and durable demand. If this is being driven by a handful of high-demand programs, the real watch item is mix: margins can stay elevated while backlog quality and customer concentration become the swing factors over the next 2-3 reporting cycles. That creates a sharper setup for a future reset if growth normalizes faster than consensus expects.

The contrarian view is that the selloff may be mechanically overdone relative to the size of the guidance raise. A move like this often reflects positioning and profit-taking rather than a deterioration in the fundamental story, especially when estimate revisions lag the company’s own outlook by a quarter or more. If management can confirm that the higher run-rate is not purely one-time or inventory-driven, the stock has room to recapture a meaningful portion of today’s drawdown over the next 30-90 days.

Key Decisions for Investors

• Buy CLS on weakness over the next 1-3 trading sessions, targeting a 6-10% rebound if the market re-rates the guidance increase; use a tight stop below the post-earnings low because the risk is a continued multiple compression rather than a fundamentals miss.
• For accounts that want lower beta exposure, express the view via CLS call spreads 1-2 months out; the setup favors convexity because implied downside may already be crowded after the 15% reset.
• Pair trade: long CLS / short a higher-multiple peer in the same outsourced manufacturing or hardware-adjacent complex if valuation divergence widens; this isolates company-specific estimate revision upside while hedging sector tape risk.